Filament Health Looks to , Natural Sources of Psychedelics , for a Number of Treatments.
'The Independent' reports that numerous startups have been
looking to tap into mind-altering psychedelic drugs
to treat a number of conditions, including depression.
Vancouver-based Filament Health's unique
approach seeks to extract the drugs from natural
sources, rather than synthesizing them in a laboratory.
Drugs like psilocybin and mescaline are extracted
from mushrooms and cacti to be used as
a treatment for opioid and stimulant use disorder.
Drugs like psilocybin and mescaline are extracted
from mushrooms and cacti to be used as
a treatment for opioid and stimulant use disorder.
Since our products come from natural
sources, we believe it allows people to
maintain a certain connection to how
humans have been ingesting these substances
for years and years and to important
aspects of many traditional communities, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
Since our products come from natural
sources, we believe it allows people to
maintain a certain connection to how
humans have been ingesting these substances
for years and years and to important
aspects of many traditional communities, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
'The Independent' reports that over a dozen other
companies and academic groups have been using the
company's drugs to treat depression and chronic pain.
'The Independent' reports that over a dozen other
companies and academic groups have been using the
company's drugs to treat depression and chronic pain.
A natural product contains much more
than just one single active compound,
right? And so in the case of magic
mushrooms, for instance, they contain
much more than just psilocybin. , Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
They contain other compounds
like psilocin and a dozen or
more other active ingredients, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
Filament Health's CEO, Benjamin Lightburn, told the
Associated Press that the idea could be compared to a cup
of coffee, which contains much more than just caffeine. .
It’s our hypothesis that the
presence of these other compounds
may contribute to differences or
perhaps even improvements in the
therapeutic potential of these
complex natural mixtures, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
It’s our hypothesis that the
presence of these other compounds
may contribute to differences or
perhaps even improvements in the
therapeutic potential of these
complex natural mixtures, Benjamin Lightburn, Filament Health's CEO, via 'The Independent' .
After all, these substances
did evolve in nature
alongside humans, Benjamin Lightburn, Filament Health's CEO, via 'The Independent'
